Stay updated on SG vs Docetaxel in NSCLC Clinical Trial
Sign up to get notified when there's something new on the SG vs Docetaxel in NSCLC Clinical Trial page.

Latest updates to the SG vs Docetaxel in NSCLC Clinical Trial page
- Check5 days agoChange DetectedRevision: v3.4.3 was added and Revision: v3.4.2 was removed. This appears to be a minor update to the study documents without changing the study design or eligibility.SummaryDifference0.0%

- Check12 days agoChange DetectedAdded Yellowplace, Turkey (Türkiye) as a trial site and removed Sarıyer, Turkey (Türkiye) from the locations list.SummaryDifference0.0%

- Check19 days agoNo Change Detected
- Check34 days agoChange DetectedRevision: v3.4.2 has been added. The previous v3.4.1 notice governing government funding and potential delays has been removed.SummaryDifference0.1%

- Check41 days agoChange DetectedA government funding lapse notice has been added, stating that information may not be up to date and submissions may be delayed. The page revision has been updated to v3.4.1, replacing v3.4.0.SummaryDifference0.1%

- Check48 days agoChange DetectedThe page shows minor UI text changes including a visible 'Show glossary' option, capitalization tweaks such as 'Last Update Submitted that Met QC Criteria' and 'No FEAR Act Data', and a revision tag 'Revision: v3.4.0'. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check62 days agoChange DetectedThe page shows an updated revision label: v3.3.4 was added and the previous v3.3.3 was removed.SummaryDifference0.0%

Stay in the know with updates to SG vs Docetaxel in NSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the SG vs Docetaxel in NSCLC Clinical Trial page.